Awards, appointments and announcements in the world of rheumatology
Benefits, Challenges of Musculoskeletal Ultrasound in Rheumatology
A rheumatology medical trainee relays pros, cons of ultrasound as joint imaging modality and usefulness in diagnosing, managing patients with rheumatologic disease
7 Things Ophthalmologists Want Rheumatologists to Know
Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes
Recipients of Ephraim P. Engleman Endowed Resident Research Preceptorship Award in Rheumatology Meet Physician Who Helped Shape Their Careers
Award’s namesake, 103-year-old rheumatologist Ephraim P. Engleman, MD, met 10 winners of research funding established in his name by the Rheumatology Research Foundation in 2006
Understanding the Role of Citrullination in Rheumatoid Arthritis
Activation of peptidylarginine deiminases during complement and perforin activity may be at the core of citrullinated autoantigen production in RA.
Rheumatology Drug Updates, Trials, Safety Data
Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know
Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting
Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended
Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting
Poverty, poor access to healthcare, cultural myths present challenges for rheumatologists caring for patients with RA in developing economic regions
Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine
Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments
Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 74
- Next Page »